Evidence map›Paper›PMID 42779536›Full record

ArticleCirculation research2026

Neural Mechanisms of Heart-Lung Crosstalk in Chronic Heart Failure.

Juan Hong, Samuel Gillman, Peter R Pellegrino, Gang Zhao, Rongguo Ren, Steven J Lisco, Irving H Zucker, Dong Wang, Han-Jun Wang

Abstract read
In one paragraph

Article in Circulation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Juan HongDepartment of Anesthesiology (J.H., S.G., P.R.P., S.J.L., H.-J.W.), University of Nebraska Medical Center, Omaha.
Samuel GillmanDepartment of Anesthesiology (J.H., S.G., P.R.P., S.J.L., H.-J.W.), University of Nebraska Medical Center, Omaha.ORCID 0009-0002-5070-5781
Peter R PellegrinoDepartment of Anesthesiology (J.H., S.G., P.R.P., S.J.L., H.-J.W.), University of Nebraska Medical Center, Omaha.ORCID 0000-0001-7880-7072
Gang ZhaoDepartment of Pharmaceutical Sciences (G.Z., R.R., D.W.), University of Nebraska Medical Center, Omaha.
Rongguo RenDepartment of Pharmaceutical Sciences (G.Z., R.R., D.W.), University of Nebraska Medical Center, Omaha.ORCID 0000-0002-1738-1212
Steven J LiscoDepartment of Anesthesiology (J.H., S.G., P.R.P., S.J.L., H.-J.W.), University of Nebraska Medical Center, Omaha.ORCID 0000-0003-4307-9807
Irving H ZuckerCellular and Integrative Physiology (I.H.Z.), University of Nebraska Medical Center, Omaha.ORCID 0000-0003-3636-7720
Dong WangDepartment of Pharmaceutical Sciences (G.Z., R.R., D.W.), University of Nebraska Medical Center, Omaha.ORCID 0000-0002-8340-2763
Han-Jun WangDepartment of Anesthesiology (J.H., S.G., P.R.P., S.J.L., H.-J.W.), University of Nebraska Medical Center, Omaha.ORCID 0000-0001-5906-8980

Funding

Neural Inflammation and Exercise Pressor Reflex in Heart FailureR01HL169205 · NHLBI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI HANJUN WANG · 2023 to 2026
$2.5M
Nonaddictive opioid prodrug nanomedicine for musculoskeletal painR01AR080500 · NIAMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Dong Wang · 2022 to 2026
$2.3M
Novel Neural Mechanisms underlying Lung-Heart Pathological CrosstalkR01HL152160 · NHLBI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI WANG, HANJUN · 2020 to 2023
$2.2M
ProGel Technology for Better Management of Osteoarthritis PainR44DA051278 · NIDA · ENSIGN PHARMACEUTICAL, INC · PI GOLDRING, STEVEN · 2020 to 2022
$1.9M
Novel Stellate Ganglia Chemo-ablation Approach to Treat Cardiac Arrhythmia and Cardiac Remodeling in Heart FailureR21HL170127 · NHLBI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI DUAN, BIN, WANG, HANJUN · 2023 to 2024
$422k
NHLBI NIH HHS R01 HL152160NHLBI NIH HHS R01 HL169205NHLBI NIH HHS R21 HL170127NIAMS NIH HHS R01 AR080500NIDA NIH HHS R44 DA051278
6 · The paper itself

Abstract

backgroundThe cardiac sympathetic afferent reflex and pulmonary spinal afferent reflex amplify sympathetic activity and may contribute to chronic heart failure. We hypothesized that cardiac injury triggers a cardiac nerve-mediated cytokine uptake cascade that propagates neural inflammation in thoracic dorsal root ganglia (DRGs) and drives reciprocal cardiopulmonary afferent sensitization through suppression of voltage-gated potassium channels after myocardial infarction (MI).

methodsMI was induced in rats by coronary ligation. Molecular profiling, immunofluorescence, tissue clearing, and functional assays were used to assess neuroinflammation and reflex responses.

resultsPost-MI, thoracic DRGs showed macrophage infiltration, glial activation, cytokine upregulation, and reduced voltage-gated potassium channel expression. Bulk RNA-sequencing identified enrichment of macrophage activation-related genes, and in vitro studies confirmed that proinflammatory cytokines and activated macrophages suppressed voltage-gated potassium channels and increased DRG neuron excitability. Epicardial injection of biotinylated TNF-α (tumor necrosis factor-α) demonstrated cardiac afferent-mediated cytokine transport to DRGs, inducing macrophage infiltration via a cytokine receptor-dependent mechanism. Anti-inflammatory interventions, including oral minocycline, systemic macrophage depletion, and local epidural delivery of thermo-responsive hydrogel-forming dexamethasone prodrug (ProGel-Dex), significantly reduced DRG neuroinflammation, restored voltage-gated potassium channel levels, and attenuated exaggerated cardiac sympathetic afferent reflex and pulmonary spinal afferent reflex responses. Minocycline and ProGel-Dex also improved cardiac chamber dilation in the post-MI rats.

conclusionsThese findings identify a neural inflammatory cascade involving cytokine uptake, glial activation, and macrophage activation as a contributor to cardiopulmonary afferent sensitization after MI. Targeting DRG inflammation, particularly with sustained dexamethasone delivery using ProGel-Dex, offers a prospect of precision medicine to dampen pathological sympathetic activation and improve cardiac outcomes in chronic heart failure.

Indexed as

ganglia, sensoryheart failureinflammationmacrophage activationmyocardial infarction

Identifiers

PMID42779536
PMCPMC13618749

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.